Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Restructuring Costs: 2023-2025

Historic Restructuring Costs for Maravai Lifesciences Holdings (MRVI) over the last 1 years, with Sep 2025 value amounting to $7.4 million.

  • Maravai Lifesciences Holdings' Restructuring Costs rose 184750.00% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 40.75%. This contributed to the annual value of -$1.2 million for FY2024, which is 118.78% down from last year.
  • As of Q3 2025, Maravai Lifesciences Holdings' Restructuring Costs stood at $7.4 million, which was up 123,000.00% from $6,000 recorded in Q4 2024.
  • Maravai Lifesciences Holdings' 5-year Restructuring Costs high stood at $7.4 million for Q3 2025, and its period low was -$1.2 million during Q1 2024.
  • In the last 3 years, Maravai Lifesciences Holdings' Restructuring Costs had a median value of $1,000 in 2024 and averaged $2.1 million.
  • Its Restructuring Costs has fluctuated over the past 5 years, first tumbled by 99.91% in 2024, then skyrocketed by 184,750.00% in 2025.
  • Quarterly analysis of 3 years shows Maravai Lifesciences Holdings' Restructuring Costs stood at $6.5 million in 2023, then plummeted by 99.91% to $6,000 in 2024, then skyrocketed by 184,750.00% to $7.4 million in 2025.
  • Its last three reported values are $7.4 million in Q3 2025, $6,000 for Q4 2024, and -$4,000 during Q3 2024.